Takeda will import COVID-19 - mRNA-1273 vaccine in partnership with the Japanese government. The drug is developed by Moderna, a biotechnology company. The vaccine is in the third phase of clinical trials in USA. It is planned to distribute about 50 million doses of the vaccine starting from the first half of 2021 after receiving authorization from Japanese regulatory authorities.
Takeda will import COVID-19 - mRNA-1273 vaccine in partnership with the Japanese government. The drug is developed by Moderna, a biotechnology company. The vaccine is in the third phase of clinical trials in USA. It is planned to distribute about 50 million doses of the vaccine starting from the first half of 2021 after receiving authorization from Japanese regulatory authorities. 
takeda.com
English (US) 